University of Pennsylvania:企業のM&A・提携動向(医療分野)

◆英語タイトル:University of Pennsylvania - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:GDPH67297D
◆発行会社(調査会社):GlobalData
◆発行日:2016年12月13日
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:米国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Pennsylvania (UOP) is an educational university that provides distance learning facilities for professional courses. The university offers courses such as art and archaeology, accounting, biochemistry, bioengineering, biomedical graduate studies, city and regional planning, criminology, fine arts, finance, operations and information management, telecommunications, theatre arts, and visual studies, among others. Its schools include school of arts and sciences, school of dental medicine, school of design, school of engineering and applied science, school of medicine and school of nursing. The university also offers arts, athletics, healthcare, libraries, online learning and global service facilities. UOP is headquartered in Philadelphia, Pennsylvania, the US.

University of Pennsylvania – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
University of Pennsylvania, Pharmaceuticals & Healthcare, Deal Details 17
Partnerships 17
Tempus Health Enters into Agreement with Penn Medicine 17
Liquid Biotech Enters into Research Agreement with University of Pennsylvania 18
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 19
Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 20
Biogen Enters into Co-Development Agreement with University of Pennsylvania 21
Seres Therapeutics Enters into Agreement with University of Pennsylvania 23
Audentes Therapeutics Enters into Co-Development with University of Pennsylvania 24
Genisphere Enters into Research Agreement with University of Pennsylvania 25
NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 26
Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 27
Janssen Pharma Enters into Agreement with University of Pennsylvania 28
Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 29
Epic Sciences Partners with Abramson Cancer Center 30
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 31
PTC Therapeutics Enters into Agreement with University of Pennsylvania 32
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 33
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 34
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 35
PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 36
Takara Bio Enters Into Research Agreement With University of Pennsylvania 37
Licensing Agreements 38
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 38
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 39
Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 40
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 41
Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 43
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 44
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 46
Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 48
Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 49
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children’s Hospital of Philadelphia 51
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 53
Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 54
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 55
Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 57
Advaxis Amends Its Licensing Agreement With University of Pennsylvania 58
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 59
Equity Offering 60
Tmunity Therapeutics Raises USD10 Million in Equity Financing 60
Asset Transactions 61
University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 61
Acquisition 62
University of Pennsylvania Health System To Acquire Chester County Hospital 62
University of Pennsylvania – Key Competitors 63
Key Employees 64
Locations And Subsidiaries 65
Head Office 65
Other Locations & Subsidiaries 65
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
University of Pennsylvania, Pharmaceuticals & Healthcare, Key Facts 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 13
Tempus Health Enters into Agreement with Penn Medicine 17
Liquid Biotech Enters into Research Agreement with University of Pennsylvania 18
Celgene Enters into Co-Development Agreement with Abramson Cancer Center 19
Bluepen Biomarkers Enters into Agreement with University of Pennsylvania 20
Biogen Enters into Co-Development Agreement with University of Pennsylvania 21
Seres Therapeutics Enters into Agreement with University of Pennsylvania 23
Audentes Therapeutics Enters into Co-Development with University of Pennsylvania 24
Genisphere Enters into Research Agreement with University of Pennsylvania 25
NeuroVive Pharma Enters into Research Agreement with University of Pennsylvania 26
Johnson & Johnson Consumer Enters into Research Agreement with University of Pennsylvania 27
Janssen Pharma Enters into Agreement with University of Pennsylvania 28
Lightlake Therapeutics Enters into Agreement with University of Pennsylvania 29
Epic Sciences Partners with Abramson Cancer Center 30
BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 31
PTC Therapeutics Enters into Agreement with University of Pennsylvania 32
CCFA Enters into Research Agreement with Penn Med and Nestle Health Science 33
Dimension Therapeutics Amends Research Agreement with University of Pennsylvania 34
Genzyme Enters into Co-Development Agreement with University of Florida and University of Pennsylvania 35
PolyMedix Enters Into Co-Development Agreement With University of Pennsylvania 36
Takara Bio Enters Into Research Agreement With University of Pennsylvania 37
Dimension Therapeutics Enters into Licensing Agreement with Perelman School of Medicine at the University of Pennsylvania 38
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 39
Kythera Biopharma Enters into Licensing Agreement with University of Pennsylvania 40
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania for Proviral Plasmids 41
Amyndas Pharma Enters into Licensing Agreement with University of Pennsylvania 43
Spark Therapeutics Enters into Licensing Agreement with University of Pennsylvania 44
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 46
Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania 48
Novartis Enters Into Licensing Agreement With University of Pennsylvania For CART-19 49
Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia 51
ImmunoCellular Therapeutics Enters Into Licensing Agreement With University of Pennsylvania For Dendritic-Cell Production Technology 53
Advaxis Enters Into Licensing Agreement With University of Pennsylvania For ISG15 54
Inovio Pharma Expands Licensing Agreement With University Of Pennsylvania 55
Atrin Pharmaceuticals Enters into Licensing Agreement with University of Pennsylvania 57
Advaxis Amends Its Licensing Agreement With University of Pennsylvania 58
Inovio Biomedical Expands Licensing Agreement With University Of Pennsylvania 59
Tmunity Therapeutics Raises USD10 Million in Equity Financing 60
University Of Pennsylvania Sells Portion Of Royalty Interest In Juxtapid For US$55 Million 61
University of Pennsylvania Health System To Acquire Chester County Hospital 62
University of Pennsylvania, Key Competitors 63
University of Pennsylvania, Key Employees 64
University of Pennsylvania, Subsidiaries 65

List of Figures
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 7
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 8
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 9
University of Pennsylvania, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 10
University of Pennsylvania, Medical Devices Deals, 2010 to YTD 2016 12

★海外企業調査レポート[University of Pennsylvania:企業のM&A・提携動向(医療分野)]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Standard Bank of South Africa Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Standard Bank of South Afri …
  • Itochu Corporation (8001)-石油・ガス分野:企業M&A・提携分析
    Summary Itochu Corporation (Itochu) is a trading company. It offers domestic trading, import and export, and overseas trading. The company trades in products such as textile, machinery, metals, minerals, energy, chemicals, food, general products, information and communications technology, realty, in …
  • China Food Company PLC :企業の戦略・SWOT・財務情報
    China Food Company PLC - Strategy, SWOT and Corporate Finance Report Summary China Food Company PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Northwest Territories Power Corporation:発電所・企業SWOT分析
    Northwest Territories Power Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informat …
  • Helloworld Limited:企業の戦略・SWOT・財務分析
    Helloworld Limited - Strategy, SWOT and Corporate Finance Report Summary Helloworld Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • L’Occitane International S.A.:企業の戦略・SWOT・財務分析
    L'Occitane International S.A. - Strategy, SWOT and Corporate Finance Report Summary L'Occitane International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Seoul National University Hospital:企業の戦略的SWOT分析
    Seoul National University Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Whole Foods Market, Inc.:企業の戦略・SWOT・財務分析
    SummaryWhole Foods Market, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Biglari Holdings Inc.:企業の戦略・SWOT・財務情報
    Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Biglari Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業財務及び戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus Interlong) is a biotechnology company that researches, develops, produces and markets cytokine protein therapeutic drugs and preventive biological products. The company’s products include recombinant human interferon a-2b for injecti …
  • The National Gas Company of Trinidad and Tobago Ltd:企業の戦略的SWOT分析
    The National Gas Company of Trinidad and Tobago Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • JSC Yaroslavl Commercial Bank for Social Development (OAO Yarsotsbank):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JSC Yaroslavl Commercial Bank f …
  • Stockheim GmbH and Co. KG:企業概要およびSWOT分析
    Summary Canadean's "Stockheim GmbH and Co. KG: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company h …
  • Neo Solar Power Corporation (3576):企業のM&A・提携動向(エネルギー分野)
    Summary Neo Solar Power Corporation (NSP) is an alternative energy company that conducts research, develops and manufactures solar cells and modules. The company operates through product segments such as NSP solar cell and NSP/delsolar module. It offers BiFi bifacial cell, mono-crystalline cell and …
  • Iberdrola S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Iberdrola S.A. Mergers and Acqu …
  • Best Denki Co., Ltd. (8175):企業概要、財務及び戦略的SWOT分析
    Summary Best Denki Co., Ltd. (Best Denki) is a supplier of household appliances and information communication equipment. The company conducts activities such as wholesale and retail of information communication equipment and housing equipment, household appliances, service installation work, busines …
  • HTG Molecular Diagnostics Inc (HTGM):企業の財務・戦略的SWOT分析
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Lancer Systems L.P.:企業の戦略・SWOT・財務情報
    Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report Summary Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Femasys Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Femasys Inc. (Femasys) is a medical device company that offers medical device solutions for women’s healthcare. The company offers products for permanent contraception, infertility solutions and cancer diagnosis. Its products include fembloc permanent contraceptive system, femvue saline-air …
  • China Aviation Oil (Singapore) Corporation Ltd (G92):企業概要、財務及び戦略的SWOT分析
    Summary China Aviation Oil (Singapore) Corporation Ltd (CAO) is a jet fuel trader. The company operates through its business segments such as jet fuel supply and trading, trading of other oil products and investments in oil-related assets. Its jet fuel supply and trading segment carries out the trad …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆